/Companies

Olive

6 known investors

Find your way into Olive

Sign up to see every warm intro you have to Olive

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Olive team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Olive uses AI to convert large, unstructured medical records into a date-ordered chronology with summaries and tables, flagging relevant pre-injury medical events and cross-referencing medical bills to detect missing records. It targets legal professionals handling personal injury claims and offers per-page pricing.

Investors · 6

Funding

SEC filings, press & company announcements

$106M disclosed across 1 of 4 rounds · 2020–2021

Source: company announcements and press reports — follow each round's link for the claim.

Frequently asked questions

What does Olive do?
Olive uses AI to convert large, unstructured medical records into a date-ordered chronology with summaries and tables, flagging relevant pre-injury medical events and cross-referencing medical bills to detect missing records. It targets legal professionals handling personal injury claims and offers per-page pricing.
Who are Olive's investors?
Olive's investors include Dnipro, Ascension Ventures, Drive Capital, General Catalyst, Oak HC/FT, Vista Equity Partners.
How much funding has Olive raised?
Olive has disclosed $106M raised across 1 of its 4 known rounds.